Revenue and Growth Outlook:
-
reported
pro forma revenue of
$599 million for Q3 2025, down
24% on a reported basis and
10% pro forma compared to the prior year.
- The decline was primarily due to the divestiture of the Milacron Injection Molding & Extrusion (MIME) business and lower capital equipment volume in the Advanced Process Solutions (APS) segment.
- Despite the challenges, the company raised its revenue guidance for fiscal year 2025, with updated guidance of
$2.59 billion to $2.63 billion.
Debt Reduction and Financial Strengthening:
- Hillenbrand reduced its net debt by over
$300 million during fiscal year 2025, strengthening its balance sheet through proceeds from the MIME and TerraSource sales.
- By the end of Q3, net debt was
$1.51 billion, with a net debt to pro forma adjusted EBITDA ratio of
3.9x.
- The reduction in debt and the successful refinancing of the credit facility provide financial flexibility and push out the next maturity to 2029.
APS Segment Performance:
- The APS segment experienced a
11% decline in revenue, driven by lower capital orders due to tariff uncertainty.
- Despite the decline, Hillenbrand has seen an uptick in market activity since the end of Q3, with several key orders won, providing confidence in the Q4 and full-year outlook.
- The company remains confident in the underlying markets and its competitive positioning, with expectations for order patterns to normalize as the macroeconomic environment stabilizes.
MTS Segment and Tariff Impact:
- The Molding Technology Solutions (MTS) segment saw
pro forma revenue of
$92 million, down
2% year-over-year, with growth in hot runner business offset by a decrease in mold-based sales.
- The segment's performance was affected by tariffs, and Hillenbrand has been mitigating these impacts through surcharge pricing, adjusted contract terms, and localizing supply chains.
- The company is progressing in its efforts to achieve local-for-local manufacturing capabilities to reduce tariff exposure and improve pricing.
Comments
No comments yet